Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 3766 AL 3780

The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders

Bruno V, Caraci F, Copani A, Matrisciano F, Nicoletti F, Battaglia G.

Neuropharmacology. 2017 Mar 15;115:180-192. doi: 10.1016/j.neuropharm.2016.04.044. Epub 2016 Apr 30.

Comparison of self and proxy ratings for voice handicap index and motor-related quality-of-life of individuals with Parkinson's disease

Parveen S, Goberman AM.

Int J Speech Lang Pathol. 2017 Apr;19(2):174-183. doi: 10.3109/17549507.2016.1167242. Epub 2016 May 5.

Implantation of autologous peripheral nerve grafts into the substantia nigra of subjects with idiopathic Parkinson's disease treated with bilateral STN DBS: a report of safety and feasibility

van Horne CG, Quintero JE, Gurwell JA, Wagner RP, Slevin JT, Gerhardt GA.

J Neurosurg. 2017 Apr;126(4):1140-1147. doi: 10.3171/2016.2.JNS151988. Epub 2016 May 6.

Hypoaminoacidemia Characterizes Chronic Traumatic Brain Injury

Durham WJ, Foreman JP, Randolph KM, Danesi CP, Spratt H, Masel BD, Summons JR, Singh CK, Morrison M, Robles C, Wolfram C, Kreber LA, Urban RJ, Sheffield-Moore M, Masel BE.

J Neurotrauma. 2017 Jan 15;34(2):385-390. doi: 10.1089/neu.2015.4350. Epub 2016 Jun 16.

Outpatient titration of carbidopa/levodopa enteral suspension (Duopa)

Pahwa R, Lyons KE.

Int J Neurosci. 2017 May;127(5):459-465. doi: 10.1080/00207454.2016.1193862. Epub 2016 Jun 21.

mTOR Signaling in Parkinson's Disease

Lan AP, Chen J, Zhao Y, Chai Z, Hu Y.

Neuromolecular Med. 2017 Mar;19(1):1-10. doi: 10.1007/s12017-016-8417-7. Epub 2016 Jun 4.

An updated review of Parkinson's disease genetics and clinicopathological correlations

Ferreira M, Massano J.

Acta Neurol Scand. 2017 Mar;135(3):273-284. doi: 10.1111/ane.12616. Epub 2016 Jun 8.

Impact of a person-centred community rehabilitation service on outcomes for individuals with a neurological condition

Barker RN, Sealey CJ, Polley ML, Mervin MC, Comans T.

Disabil Rehabil. 2017 Jun;39(11):1136-1142. doi: 10.1080/09638288.2016.1185803. Epub 2016 Jun 9.

Neurotransmitter release: vacuolar ATPase V0 sector c-subunits in possible gene or cell therapies for Parkinson's, Alzheimer's, and psychiatric diseases

Higashida H, Yokoyama S, Tsuji C, Muramatsu SI.

J Physiol Sci. 2017 Jan;67(1):11-17. doi: 10.1007/s12576-016-0462-3. Epub 2016 Jun 11.

Parkinson's disease impairs masticatory function

Ribeiro GR, Campos CH, Rodrigues Garcia RCM.

Clin Oral Investig. 2017 May;21(4):1149-1156. doi: 10.1007/s00784-016-1879-z. Epub 2016 Jun 13.

Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease

Gonçalves SA, Outeiro TF.

Small GTPases. 2017 Apr 3;8(2):78-84. doi: 10.1080/21541248.2016.1199191. Epub 2016 Jun 17.

A Meta-Analysis of Nonpharmacological Interventions for People With Parkinson's Disease

Lee J, Choi M, Yoo Y.

Clin Nurs Res. 2017 Oct;26(5):608-631. doi: 10.1177/1054773816655091. Epub 2016 Jun 17.

Mitochondrial function in hypoxic ischemic injury and influence of aging

Ham PB 3rd, Raju R.

Prog Neurobiol. 2017 Oct;157:92-116. doi: 10.1016/j.pneurobio.2016.06.006. Epub 2016 Jun 16.

Alpha-synuclein modulates dopamine neurotransmission

Butler B, Sambo D, Khoshbouei H.

J Chem Neuroanat. 2017 Oct;83-84:41-49. doi: 10.1016/j.jchemneu.2016.06.001. Epub 2016 Jun 19.

Observational study of quality of life of Parkinson's patients and their caregivers

Corallo F, De Cola MC, Lo Buono V, Di Lorenzo G, Bramanti P, Marino S.

Psychogeriatrics. 2017 Mar;17(2):97-102. doi: 10.1111/psyg.12196. Epub 2016 Jun 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias